Moreover, the information of endogenous islet neogenic potential seems to be very useful in designing newer therapeutic approaches and target molecules, governing TGF-β mediated signaling pathway to treat diabetes mellitus. This evidence concerns the gene TGFB1 and diabetes mellitus.